Last updated on February 2018

Protocol Establishment for the Prevention of Lamotrigine-induced Skin Rash in Epilepsy Patients


Brief description of study

The investigators intend to find a way to lower drug rash occurrence by applying drug tolerance induction protocol at the beginning of lamotrigine administration.

Genotyping of participants with rash and those without rash after taking lamotrigine and genetic testing to find common gene mutations in these participants.

Clinical Study Identifier: NCT03220256

Find a site near you

Start Over